Health
MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines – News-Medical.Net
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells…
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted…
Continue Reading
-
General21 hours agoIran-Israel conflict: Israel strikes Iran’s oil and gas fields, as Tehran warns of ‘more severe’ response
-
General19 hours agoHelp for disabled youths left at the mercy of carers
-
General20 hours agoAnthony Albanese to meet Donald Trump at G7 talks in Canada
-
Noosa News10 hours agoSupernova? High-speed stunt for mystery movie in CBD